- Home
- AB vs PTCT Comparison
AB vs PTCT Comparison
Compare AB & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AB
- PTCT
- Stock Information
- Founded
- AB 1987
- PTCT 1998
- Country
- AB United States
- PTCT United States
- Employees
- AB N/A
- PTCT N/A
- Industry
- AB Investment Managers
- PTCT Biotechnology: Pharmaceutical Preparations
- Sector
- AB Finance
- PTCT Health Care
- Exchange
- AB Nasdaq
- PTCT Nasdaq
- Market Cap
- AB 4.5B
- PTCT 4.8B
- IPO Year
- AB 1988
- PTCT 2013
- Fundamental
- Price
- AB N/A
- PTCT $64.73
- Analyst Decision
- AB Hold
- PTCT Buy
- Analyst Count
- AB 5
- PTCT 14
- Target Price
- AB $40.40
- PTCT $67.00
- AVG Volume (30 Days)
- AB 146.1K
- PTCT 1.3M
- Earning Date
- AB 10-23-2025
- PTCT 11-06-2025
- Dividend Yield
- AB 8.48%
- PTCT N/A
- EPS Growth
- AB 17.05
- PTCT N/A
- EPS
- AB 3.37
- PTCT 7.72
- Revenue
- AB N/A
- PTCT $1,764,929,000.00
- Revenue This Year
- AB N/A
- PTCT $119.89
- Revenue Next Year
- AB $7.42
- PTCT N/A
- P/E Ratio
- AB $11.47
- PTCT $8.35
- Revenue Growth
- AB N/A
- PTCT 96.00
- 52 Week Low
- AB $32.28
- PTCT $35.14
- 52 Week High
- AB $43.30
- PTCT $67.40
- Technical
- Relative Strength Index (RSI)
- AB 51.86
- PTCT 64.81
- Support Level
- AB $37.25
- PTCT $62.32
- Resistance Level
- AB $38.90
- PTCT $67.40
- Average True Range (ATR)
- AB 0.60
- PTCT 2.11
- MACD
- AB 0.13
- PTCT 0.06
- Stochastic Oscillator
- AB 75.48
- PTCT 58.85
About AB AllianceBernstein Holding L.P.
AllianceBernstein provides investment management services to institutional (41% of assets under management), retail (42%), and private (17%) clients through products that includes mutual funds, hedge funds, and separately managed accounts. At the end of June 2025, the company had $829 billion in managed assets, composed primarily of fixed-income (37% of AUM) and equity (41%) strategies, with other investments (made up of asset allocation services and certain other alternative investments) accounting for the remainder.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.